First description of Trypanosoma cruzi human infection in Esmeraldas province, Ecuador
- Ángel Guevara1Email author,
- Juan Moreira^1, 2,
- Hipatia Criollo1,
- Sandra Vivero1,
- Marcia Racines1,
- Varsovia Cevallos3,
- Rosanna Prandi2,
- Cynthia Caicedo2,
- Francisco Robinzon2 and
- Mariella Anselmi2, 4
© Guevara et al.; licensee BioMed Central Ltd. 2014
Received: 12 June 2014
Accepted: 16 July 2014
Published: 6 August 2014
Chagas disease was described in Ecuador in 1930 in the province of Guayas and thereafter in various provinces. Triatomine were reported in the province of Esmeraldas but no human infection has been described. Here we report the first evidence that the disease does exist in the province of Esmeraldas. In indigenous Awá communities located in the northwest jungle of the Esmeraldas province, 144 individuals were tested using ELISA and PCR for T.cruzi of which 5 (3.47%) were positive. Twenty eight triatomine were collected, 27 were Triatoma dispar and 1 Pastrongylus rufotuberculatus, T.cruzi was detected in 11 (42.3%) of 26 insects.
KeywordsTriatoma dispar L Trypanosoma cruzi Ecuador Esmeraldas Awá population Chagas disease
Chagas disease or American trypanosomiasis, is caused by an infection by the protozoan hemoflagellate Trypanosoma cruzi, which is transmitted to humans through bites of infected triatomine insects. The infection is widespread throughout Latin America although an increasing number of cases in non-endemic countries have been described . In Ecuador, human T.cruzi infections have been observed in different provinces since 1930 [2, 3]. However, in the Esmeraldas province, although triatomine insects were reported, autochthonous cases of T.cruzi human infection have not been documented . The province of Esmeraldas, bordering the southern regions of Colombia, is located in the northwest of the country. Most of the inhabitants are of African descendant with dispersed indigenous populations such as the Epera, Chachi and Awá. The latter are also called kwaike r, speak their own language (Awá pit) and live in remote areas, isolated from any urban areas. Reports from individuals from three Awá’s villages: Mataje Alto (17 N 0772280, UTM 0134144, 221 m), Pambilar (17 N 0766542, UTM 0124494, 144 m) and Balsareño (17 N 0761275, UTM 0128009, 44 m) revealed the presence of triatomine insects in their homes and in peridomestic areas. Therefore, a protocol to study insects and human blood of Awá population was prepared and approved by the Bioethics Committee COBI-ASFORUM (Federalwide Assurance FWZ00002482, IEC IORG0001932, IRB00002438, IEPIDNPI 125754-12/132854-13) in Quito-Ecuador.
Triatomine insects collected in Awá’s communities of northwest jungle of Esmeraldas province, Ecuador
Results expressed in absorbance values from human sera samples with three different ELISA tests
The present study demonstrates human T.cruzi infection in the northwest jungle of Ecuador. The extent of the infection as well as the associated Chagas disease pathology, if any, in the Awá population remains to be determined. In any case, our findings should alert Ecuadorian health authorities to start an integrated strategy to provide treatment and prevention measures to avoid further transmission. Triatoma dispar Lent is considered as a sylvatic species and has been reported in the northeast jungle of Ecuador  but not in the northwest jungle, in this letter 27 (96%) of 28 triatomine insects collected in northwest province of Esmeraldas were T.dispar L and many of them were collected in domestic areas. Studies related to vector biology and T.cruzi genotyping in vectors, human beings and wild reservoirs are required to understand the dynamics of T.cruzi transmission in this particular area since triatomine vectors had been shown an ease move from wild to domestic areas .
We thank the Federación de Pueblos Awá for their support in the field. Thanks to Ronald Guderian and Thomas Unnasch for critical reviewing of the manuscript.
- Bonney K: Chagas disease in the 21st century: a public health success or an emerging threat?. Parasite. 2014, 21: 11.PubMed CentralView ArticlePubMedGoogle Scholar
- Aguilar M, Abad–Franch F, Racines J, Paucar A: Epidemiology of Chagas disease in Ecuador. A brief review. Mem Inst Oswaldo Cruz. 1999, 94: 387-393.View ArticleGoogle Scholar
- Arteaga C: Investigaciones sobre la existencia de la enfermedad de Chagas en la zona del ferrocarril de la Costa (Provincia del Guayas). Rev Univ Guayaquil. 1930, 1: 89-101.Google Scholar
- Guevara A, Garzón E, Bowen C, Córdova X, Gómez E, Ouaissi A: High infection rates of Triatoma dimidiata are associated with low levels of Trypanosoma cruzi seroprevalence in Pedro Carbo, Ecuador: Use of a tc 24 gene-based PCR approach. Parasite. 2005, 12: 65-68. 10.1051/parasite/2005121065.View ArticlePubMedGoogle Scholar
- Smith B, Conlan C, Hwang W, Weirauch C: Polymerase Chain Reaction Detection of Trypanosoma cruzi in Suboptimally Preserved Vectors and Comparative Infection Rates 2007–2010 in Escondido Southern California. Vector-Borne Zoonotic Dis. 2011, 11 (12): 1603-1604. 10.1089/vbz.2011.0710.View ArticlePubMedGoogle Scholar
- Guevara A, Eras J, Recalde M, Vinueza L, Cooper P, Ouassi A, Guderian R: Severe digestive pathology associated with chronic Chagas disease in Ecuador: report of two cases. Rev Soc Bras Med Trop. 1997, 30: 389-392. 10.1590/S0037-86821997000500007.View ArticlePubMedGoogle Scholar
- Kirchhoff L, Votava J, Ochs D, Moser D: Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J Clin Microb. 1996, 34 (5): 1171-1175.Google Scholar
- Zeledon R, Ugalde J, Paniagua L: Entomological and Ecological Aspects of Six Sylvatic Species of Triatomines (Hemiptera, Reduviidae) from the Collection of the National Biodiversity Institute of Costa Rica, Central America. Mem Inst Oswaldo Cruz Rio de Janeiro. 2001, 96 (6): 757-764. 10.1590/S0074-02762001000600002.View ArticleGoogle Scholar
- Grijalva M, Villacís A, Ocaña S, Yumiseva C, Baus E: Limitations of selective deltamethrin application for triatomine control in central coastal Ecuador. Parasites & Vectors. 2011, 4: 20-10.1186/1756-3305-4-20.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.